General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kowalczyk M et al. – The authors highlight that sumatriptan effectively aborted symptoms in an adult patient with cyclic vomiting syndrome. Increasing physicians’ awareness of adult cyclic vomiting syndrome may improve care of patients suffering from this debilitating condition.


Related Articles

The Safety of Sumatriptan and Naratriptan in Pregnancy: What Have We Learned?
Headache: The Journal of Head and Face Pain, 10/07/09    Relevance Score: 89%

Needle-Free Subcutaneous Sumatriptan (Sumavel DosePro): Bioequivalence and Ease of Use
Headache: The Journal of Head and Face Pain, 10/26/09    Relevance Score: 87%

APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP
American Pharmaceutical Partners, 10/09/09    Relevance Score: 87%

Successful Treatment With Sumatriptan in a Case With Cyclic Vomiting Syndrome Combined With 18q– Syndrome
Journal of Child Neurology, 10/02/09    Relevance Score: 87%

FDA Approves APPs Generic Imitrex for Migraines
Internet Source, 10/14/09    Relevance Score: 84%

Today in Pharmacology/kinetics...keeping you current

Rectal cancer and adjuvant chemotherapy: which conclusions
Bulletin du Cancer, 02/09/10

Mesalazine in inflammatory bowel disease: A trendy topic once again
Canadian Journal of Gastroenterology, 02/09/10

Algorithms Outperform Metabolite Tests in Predicting Response of Patients With Inflammatory Bowel Disease to Thiopurines
Clinical Gastroenterology and Hepatology , 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address